Source Feed: Global News - Canada
Author: Globalnews Digital
Publication Date: July 16, 2026 - 09:35
Stay informed
Unpublished Opinions
Add Alzheimer’s drug lecanemab to Canada’s public drug plans, agency says
July 16, 2026
Lecanemab is an antibody that targets the buildup of amyloid plaque in the brain, which is believed to be an underlying cause of the disease.
Unpublished Newswire
It started as a few guys looking for camaraderie after the COVID-19 pandemic. Now, Men's Sheds Lethbridge and Coaldale has become a thriving non-profit in southern Alberta.
August 5, 2026 - 23:59 | Justin Sibbet | Global News - Canada
August 5, 2026 - 22:22 | Om Shanbhag, Jesse Winter | The Globe and Mail
August 5, 2026 - 22:03 | Colin Freeze, Sara Mojtehedzadeh, Marie Woolf | The Globe and Mail
Comments
Be the first to comment